Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Deciphering the Oncogenic Landscape: Unveiling the Molecular Machinery and Clinical Significance of Lncrna Tmpo-As1 in Human Cancers Publisher Pubmed



Saraswat SK1 ; Mahmood BS2 ; Ajila F3 ; Kareem DS4 ; Alwan M5 ; Athab ZH6 ; Shaier JB7 ; Hosseinifard SR8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of ECE, GLA University Mathura, 281406, India
  2. 2. Department of Anesthesia Techniques, Al-Noor University College, Nineveh, Iraq
  3. 3. Facultad de Informatica y Electronica, Escuela Superior Politecnica de Chimborazo (ESPOCH), Sede Orellana, El Coca, 220001, Ecuador
  4. 4. National University of Science and Technology, Dhi Qar, Iraq
  5. 5. Medical Technical College, Al-Farahidi University, Iraq
  6. 6. Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq
  7. 7. Ministry of Education, Babil Education Directorate, Babil, Iraq
  8. 8. Biochemistry Department, Tehran University of Medical Sciences, Tehran, Iran

Source: Pathology Research and Practice Published:2024


Abstract

The in-depth exploration of long non-coding RNAs (lncRNAs) reveals their pivotal and diverse roles in various disorders, particularly cancer. Within this intricate landscape, thymopoietin-antisense RNA-1 (TMPO-AS1) emerges as a noteworthy instigator of oncogenesis in humans. This exhaustive review seeks to intricately unravel the present understanding of TMPO-AS1, emphasizing its molecular foundations and highlighting its clinical applications in the realm of cancer research. TMPO-AS1 consistently exhibits heightened expression across a spectrum of cancer types, encompassing lung, colorectal, breast, cervical, bladder, pancreatic, hepatocellular, gastric, ovarian, and osteosarcoma. Elevated levels of TMPO-AS1 are intricately linked to unfavorable prognoses, accompanied by distinctive clinical and pathological characteristics. Functionally, TMPO-AS1 showcases its prowess in enhancing cancer cell migration, invasion, proliferation, and orchestrating epithelial-mesenchymal transition (EMT) through a myriad of molecular mechanisms. These mechanisms entail intricate interactions with proteins, microRNAs, and intricate signaling pathways. Furthermore, TMPO-AS1 is intricately involved in regulating critical cellular processes, including apoptosis and the cell cycle. The mounting evidence converges towards the potential of TMPO-AS1 serving as a diagnostic and prognostic biomarker, further entwined with its potential role in influencing chemoresistance in cancer. This potential is underscored by its consistent associations with clinical outcomes and treatment responses. This comprehensive investigation not only consolidates our existing knowledge of TMPO-AS1's multifaceted roles but also sheds illuminating insights on its profound significance in the intricate landscape of cancer biology, paving the way for potential applications in clinical practice. © 2024 Elsevier GmbH
Related Docs
View other Related Docs
1. An Overview of Long Noncoding Rnas: Biology, Functions, Therapeutics, Analysis Methods, and Bioinformatics Tools, Cell Biochemistry and Function (2022)
2. Heterogeneous Expression of Long Noncoding Rna Rp11-109D20.2: Insights Into Regulatory Gene Expression Roles in Colon Cancer, Iranian Journal of Basic Medical Sciences (2025)
3. Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles, Critical Reviews in Oncology/Hematology (2021)
4. Opium Use and Risk of Colorectal Cancer: A Multi-Center Case-Referent Study in Iran, Acta Oncologica (2023)
5. Expression Analysis of Five Different Long Non-Coding Ribonucleic Acids in Nonsmall-Cell Lung Carcinoma Tumor and Tumor-Derived Exosomes, Diagnostics (2022)
6. A Systematic Review of Long Non-Coding Rnas With a Potential Role in Breast Cancer, Mutation Research - Reviews in Mutation Research (2021)
7. Cdkn2b-As1 As a Novel Therapeutic Target in Cancer: Mechanism and Clinical Perspective, Biochemical Pharmacology (2023)
8. Trends in Incidence of Prostate Cancer in Iran and Its 31 Provinces During 2003 - 2016, International Journal of Cancer Management (2023)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (8)
Bagher Larijani (8)
Other Related Docs
9. Long Non-Coding Rnas (Lncrnas); Roles in Tumorigenesis and Potentials As Biomarkers in Cancer Diagnosis, Experimental Cell Research (2022)
10. The Role of Long Noncoding Rnas (Lncrnas) in the Pathogenesis of Chemoresistance in Endometrial Cancer: A Molecular Approach and Future Perspective, Indian Journal of Gynecologic Oncology (2025)
11. Emerging Roles of Non-Coding Rnas in Modulating the Pi3k/Akt Pathway in Cancer, Non-coding RNA Research (2025)
12. Dysregulated Linc01133 Expression in Laryngeal Carcinoma: Prognostic Implications and Predicted Cerna Interactome, Molecular Biology Research Communications (2025)
13. Integrated Bioinformatics and Wet-Lab Analysis Revealed Cell Adhesion Prominent Genes Cdc42, Tagln and Gsn As Prognostic Biomarkers in Colonic-Polyp Lesions, Scientific Reports (2023)
14. The Expression of Sox10 and Its Value for Predicting Tumor Biological Behaviors in Patients Suffering Gastric Adenocarcinoma, Cross Sectional Study, International Journal of Surgery Open (2022)
15. National and Subnational Burden of Female and Male Breast Cancer and Risk Factors in Iran From 1990 to 2019: Results From the Global Burden of Disease Study 2019, Breast Cancer Research (2023)
16. Down-Regulation of a Panel of Immune-Related Lncrnas in Breast Cancer, Pathology Research and Practice (2021)
17. Global Epidemiology and Socioeconomic Correlates of Salivary Gland Cancer From 2020 to 2040, Community Dentistry and Oral Epidemiology (2025)
18. Anti-Tumor Activity of Neratinib, a Pan-Her Inhibitor, in Gastric Adenocarcinoma Cells, European Journal of Pharmacology (2019)
19. An Update to Experimental and Clinical Aspects of Tumor-Associated Macrophages in Cancer Development: Hopes and Pitfalls, Clinical and Experimental Medicine (2024)
20. The Role of Her2 Alterations in Clinicopathological and Molecular Characteristics of Breast Cancer and Her2-Targeted Therapies: A Comprehensive Review, Medical Oncology (2022)
21. A Systematic Review and Meta-Analysis to Evaluate Blood Levels of Interleukin-6 in Lung Cancer Patients, Kardiochirurgia i Torakochirurgia Polska (2023)
22. Critical Involvement of Circular Rnas in Virus-Associated Cancers, Genes and Diseases (2023)
23. Direct and Indirect Medical Costs of Bladder Cancer in Iran, Cost Effectiveness and Resource Allocation (2023)
24. Constructing Mrna, Mirna, Circrna and Lncrna Regulatory Network by Analysis of Microarray Data in Breast Cancer, Gene Reports (2022)
25. Regulation of Long Non-Coding Rnas by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach, Cancers (2021)
26. Naturally Nutrient Rich (Nnr) Score and the Risk of Colorectal Cancer: A Case-Control Study, BMJ Open Gastroenterology (2023)
27. The Microrna Let-7 and Its Exosomal Form: Epigenetic Regulators of Gynecological Cancers, Cell Biology and Toxicology (2024)
28. Using a Social Marketing Approach to Increase the Pap-Smear Test Uptake: Randomized Controlled Trial Among Women Residing in Urban Region, BMC Women's Health (2025)
29. Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause From Global Burden of Disease 1990-2019, Hepatology Communications (2022)
30. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
31. Differential Gene Expression of Bcl-2, Zeb2‑As1 and Balr-2 in Prostate Cancer and Benign Prostatic Hyperplasia, Andrologia (2022)
32. Association of Imaging and Pathological Findings of Breast Cancer in Very Young Women: Report of a Twenty-Year Retrospective Study, Clinical Imaging (2024)
33. Synthesis of Silver-Doxycycline Complex Nanoparticles and Their Biological Evaluation on Mcf-7 Cell Line of the Breast Cancer, Journal of Chemistry (2021)
34. Anti-Cd20 Antibody Treatment for B-Cell Malignancies, Resistance to Anti-CD20 Antibodies and approaches for their Reversal: Volume 2 (2023)
35. The Epidemiology of Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)
36. Immunotherapeutic Targets in Non-Small Cell Lung Cancer, Immunology (2023)
37. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
38. Principles of Pharmacogenomics and Pharmacogenetics, Precision Medicine in Clinical Practice (2022)
39. Sleep Disturbance and Gastrointestinal Cancer Risk: A Literature Review, Journal of Investigative Medicine (2023)
40. Naringenin: A Potential Flavonoid Phytochemical for Cancer Therapy, Life Sciences (2022)
41. Hotair Long Noncoding Rna Is Not a Biomarker for Acute Myeloid Leukemia (Aml) in Iranian Patients, Asian Pacific Journal of Cancer Prevention (2017)
42. Combining Nanotechnology and Gas Plasma As an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication, Oxidative Medicine and Cellular Longevity (2021)
43. Advances in Therapeutic Targeting of Immune Checkpoints Receptors Within the Cd96-Tigit Axis: Clinical Implications and Future Perspectives, Expert Review of Clinical Immunology (2022)
44. Establishing Core Data Elements for Colorectal Cancer and Mapping to Fhir Resources: Towards Interoperable Iranian Health Information Systems, Journal of Education and Health Promotion (2025)
45. Role of Lncrna Pvt1 in the Progression of Urological Cancers: Novel Insights Into Signaling Pathways and Clinical Opportunities, Cellular Signalling (2025)
46. Toxic Mechanisms of Cadmium and Exposure As a Risk Factor for Oral and Gastrointestinal Carcinomas, Human and Experimental Toxicology (2023)
47. Investigating Socioeconomic Inequality in the Incidence of Breast Cancer in Iran: Interprovincial Analysis and Comparison, Scientific Journal of Kurdistan University of Medical Sciences (2025)
48. Systematic Review and Meta-Analysis of the Association Between the Use of Sglt2 Inhibitors and Hepatocellular Carcinoma, Immunopathologia Persa (2025)
49. A High-Performance Electrochemical Aptasensor Based on Graphene-Decorated Rhodium Nanoparticles to Detect Her2-Ecd Oncomarker in Liquid Biopsy, Scientific Reports (2022)
50. Pattern of Participation in Colorectal Cancer Screening From a Population-Based Screening Program in Iran, Archives of Iranian Medicine (2024)